NASDAQ: PYXS
Pyxis Oncology Inc Stock Ownership - Who owns Pyxis Oncology?

Insider buying vs selling

Have Pyxis Oncology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Pamela Ann ConnealyCFO COO2024-11-2683,400$1.96
$163.46kBuy
Pamela Ann ConnealyCFO COO2024-11-265,450$2.00
$10.90kBuy

1 of 1

PYXS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PYXS insiders and whales buy or sell their stock.

PYXS Shareholders

What type of owners hold Pyxis Oncology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Pfizer Inc11.42%7,032,770$7.31MInstitution
Pfizer Inc11.42%7,032,770$7.31MInsider
Laurion Capital Management LP5.89%3,625,974$3.77MInstitution
Barclays PLC5.65%3,477,975$3.62MInsider
Pamela Ann Connealy5.56%3,425,179$3.56MInsider
Blackrock Inc5.43%3,344,141$3.48MInstitution
Millennium Management LLC4.84%2,980,906$3.10MInstitution
Bayer World Investments Bv4.45%2,742,338$2.85MInsider
Vanguard Group Inc3.96%2,441,153$2.54MInstitution
Lara Sullivan3.90%2,403,882$2.50MInsider

1 of 3

PYXS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PYXS51.20%37.91%Net Buying
RANI6.64%38.47%Net Selling
ABOS70.15%17.11%Net Selling
NTRB2.20%50.83%
CABA75.81%8.32%

Pyxis Oncology Stock Ownership FAQ

Who owns Pyxis Oncology?

Pyxis Oncology (NASDAQ: PYXS) is owned by 51.20% institutional shareholders, 37.91% Pyxis Oncology insiders, and 10.88% retail investors. Pfizer Inc is the largest individual Pyxis Oncology shareholder, owning 7.03M shares representing 11.42% of the company. Pfizer Inc's Pyxis Oncology shares are currently valued at $7.31M.

If you're new to stock investing, here's how to buy Pyxis Oncology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.